.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Asia Healthcare Holdings appointments mark a significant step in the platform's governance evolution. The GIC and TPG-backed entity recently added three seasoned professionals to its board of directors. Consequently, these leaders will oversee the strategic direction of major specialty chains across India. Furthermore, these additions bring extensive experience from the consumer, industrial, and healthcare sectors to the organization.
Murali Sivaraman now serves as the non-executive independent director and board chairperson. Previously, he held executive roles at Royal Philips and the Investment Company Institute. Moreover, Vinita Bali joins as a non-executive independent director and NRC chairperson. She formerly led Britannia Industries and held senior positions at Coca-Cola. Additionally, Rashmi Joshi takes the role of audit committee chairperson. Her background includes CFO roles at Veedol Corporation and Castrol India. Notably, these appointments became effective on May 1, 2026.
The board also includes representatives from GIC and TPG Growth. These members include Cynthia Lau, Mayank Rawat, and Ankur Thadani. Currently, AHH operates prominent brands like Motherhood Hospitals and Nova IVF Fertility. Similarly, it manages the Asian Institute of Nephrology and Urology. These chains span over 80 cities in India. Consequently, the network includes 150 hospitals and 2,000 doctors. This leadership change will likely accelerate their clinical and operational excellence across the country.
Q1: Who is the new chairperson of Asia Healthcare Holdings?
Murali Sivaraman, a former executive at Royal Philips, has been appointed as the non-executive independent director and board chairperson.
Q2: Which healthcare brands does AHH currently operate in India?
AHH operates three major specialty chains: Motherhood Hospitals, Nova IVF Fertility, and the Asian Institute of Nephrology and Urology (AINU).
Q3: What is the scale of the Asia Healthcare Holdings network?
The network operates across 80-plus cities in India, featuring over 150 hospitals and clinics, supported by 2,000 doctors and 6,100 employees.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AHH appoints Murali Sivaraman, Vinita Bali, and Rashmi Joshi to its board to oversee Motherhood Hospitals, Nova IVF, and AINU's nationwide expansion....
5 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
